What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News PRISM BioLab and Talus Bioscience aim to crack the transcription factor code with dual-platform drug discovery strategy PRISM BioLab and Talus Bio have teamed up to crack transcription factor drug discovery. Find out how their dual-platform strategy could reshape precision medicine. byVenkateshDecember 18, 2025